P21-activated kinase in inflammatory and cardiovascular disease

Domenico M. Taglieri, Masuko Ushio-Fukai, Michelle M. Monasky

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

P-21 activated kinases, or PAKs, are serine-threonine kinases that serve a role in diverse biological functions and organ system diseases. Although PAK signaling has been the focus of many investigations, still our understanding of the role of PAK in inflammation is incomplete. This review consolidates what is known about PAK1 across several cell types, highlighting the role of PAK1 and PAK2 in inflammation in relation to NADPH oxidase activation. This review explores the physiological functions of PAK during inflammation, the role of PAK in several organ diseases with an emphasis on cardiovascular disease, and the PAK signaling pathway, including activators and targets of PAK. Also, we discuss PAK1 as a pharmacological anti-inflammatory target, explore the potentials and the limitations of the current pharmacological tools to regulate PAK1 activity during inflammation, and provide indications for future research. We conclude that a vast amount of evidence supports the idea that PAK is a central molecule in inflammatory signaling, thus making PAK1 itself a promising prospective pharmacological target.

Original languageEnglish
Pages (from-to)2060-2069
Number of pages10
JournalCellular Signalling
Volume26
Issue number9
DOIs
Publication statusPublished - 2014

Fingerprint

p21-Activated Kinases
Cardiovascular Diseases
Inflammation
Pharmacology
NADPH Oxidase
Protein-Serine-Threonine Kinases
Anti-Inflammatory Agents

Keywords

  • Cardiac
  • Cell migration
  • Cytoskeletal dynamics
  • NADPH oxidase
  • PAK1
  • PAK2

ASJC Scopus subject areas

  • Cell Biology
  • Medicine(all)

Cite this

P21-activated kinase in inflammatory and cardiovascular disease. / Taglieri, Domenico M.; Ushio-Fukai, Masuko; Monasky, Michelle M.

In: Cellular Signalling, Vol. 26, No. 9, 2014, p. 2060-2069.

Research output: Contribution to journalArticle

Taglieri, Domenico M. ; Ushio-Fukai, Masuko ; Monasky, Michelle M. / P21-activated kinase in inflammatory and cardiovascular disease. In: Cellular Signalling. 2014 ; Vol. 26, No. 9. pp. 2060-2069.
@article{1307bbca42d44970b5bb60a446097f84,
title = "P21-activated kinase in inflammatory and cardiovascular disease",
abstract = "P-21 activated kinases, or PAKs, are serine-threonine kinases that serve a role in diverse biological functions and organ system diseases. Although PAK signaling has been the focus of many investigations, still our understanding of the role of PAK in inflammation is incomplete. This review consolidates what is known about PAK1 across several cell types, highlighting the role of PAK1 and PAK2 in inflammation in relation to NADPH oxidase activation. This review explores the physiological functions of PAK during inflammation, the role of PAK in several organ diseases with an emphasis on cardiovascular disease, and the PAK signaling pathway, including activators and targets of PAK. Also, we discuss PAK1 as a pharmacological anti-inflammatory target, explore the potentials and the limitations of the current pharmacological tools to regulate PAK1 activity during inflammation, and provide indications for future research. We conclude that a vast amount of evidence supports the idea that PAK is a central molecule in inflammatory signaling, thus making PAK1 itself a promising prospective pharmacological target.",
keywords = "Cardiac, Cell migration, Cytoskeletal dynamics, NADPH oxidase, PAK1, PAK2",
author = "Taglieri, {Domenico M.} and Masuko Ushio-Fukai and Monasky, {Michelle M.}",
year = "2014",
doi = "10.1016/j.cellsig.2014.04.020",
language = "English",
volume = "26",
pages = "2060--2069",
journal = "Cellular Signalling",
issn = "0898-6568",
publisher = "Elsevier Inc.",
number = "9",

}

TY - JOUR

T1 - P21-activated kinase in inflammatory and cardiovascular disease

AU - Taglieri, Domenico M.

AU - Ushio-Fukai, Masuko

AU - Monasky, Michelle M.

PY - 2014

Y1 - 2014

N2 - P-21 activated kinases, or PAKs, are serine-threonine kinases that serve a role in diverse biological functions and organ system diseases. Although PAK signaling has been the focus of many investigations, still our understanding of the role of PAK in inflammation is incomplete. This review consolidates what is known about PAK1 across several cell types, highlighting the role of PAK1 and PAK2 in inflammation in relation to NADPH oxidase activation. This review explores the physiological functions of PAK during inflammation, the role of PAK in several organ diseases with an emphasis on cardiovascular disease, and the PAK signaling pathway, including activators and targets of PAK. Also, we discuss PAK1 as a pharmacological anti-inflammatory target, explore the potentials and the limitations of the current pharmacological tools to regulate PAK1 activity during inflammation, and provide indications for future research. We conclude that a vast amount of evidence supports the idea that PAK is a central molecule in inflammatory signaling, thus making PAK1 itself a promising prospective pharmacological target.

AB - P-21 activated kinases, or PAKs, are serine-threonine kinases that serve a role in diverse biological functions and organ system diseases. Although PAK signaling has been the focus of many investigations, still our understanding of the role of PAK in inflammation is incomplete. This review consolidates what is known about PAK1 across several cell types, highlighting the role of PAK1 and PAK2 in inflammation in relation to NADPH oxidase activation. This review explores the physiological functions of PAK during inflammation, the role of PAK in several organ diseases with an emphasis on cardiovascular disease, and the PAK signaling pathway, including activators and targets of PAK. Also, we discuss PAK1 as a pharmacological anti-inflammatory target, explore the potentials and the limitations of the current pharmacological tools to regulate PAK1 activity during inflammation, and provide indications for future research. We conclude that a vast amount of evidence supports the idea that PAK is a central molecule in inflammatory signaling, thus making PAK1 itself a promising prospective pharmacological target.

KW - Cardiac

KW - Cell migration

KW - Cytoskeletal dynamics

KW - NADPH oxidase

KW - PAK1

KW - PAK2

UR - http://www.scopus.com/inward/record.url?scp=84904288300&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904288300&partnerID=8YFLogxK

U2 - 10.1016/j.cellsig.2014.04.020

DO - 10.1016/j.cellsig.2014.04.020

M3 - Article

C2 - 24794532

AN - SCOPUS:84904288300

VL - 26

SP - 2060

EP - 2069

JO - Cellular Signalling

JF - Cellular Signalling

SN - 0898-6568

IS - 9

ER -